These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18790977)

  • 1. Which tools can I use in daily clinical practice to improve tailoring of treatment for breast cancer? The 2007 St Gallen guidelines and/or Adjuvant! Online.
    Cufer T
    Ann Oncol; 2008 Sep; 19 Suppl 7():vii41-5. PubMed ID: 18790977
    [No Abstract]   [Full Text] [Related]  

  • 2. Which tools can I use in daily clinical practice to improve tailoring of treatment for breast cancer? Treatment decision-making in advanced disease.
    Smith IE
    Ann Oncol; 2008 Sep; 19 Suppl 7():vii51-7. PubMed ID: 18790980
    [No Abstract]   [Full Text] [Related]  

  • 3. The community clinical oncology program: its effect on clinical practice.
    Warnecke RB; Johnson TP; Kaluzny AD; Ford LG
    Jt Comm J Qual Improv; 1995 Jul; 21(7):336-9. PubMed ID: 7581736
    [No Abstract]   [Full Text] [Related]  

  • 4. The Changing Role of Gene-Expression Profiling in the Era of De-escalating Adjuvant Chemotherapy in Early-Stage Breast Cancer.
    van Steenhoven JEC; Kuijer A; Schreuder K; Elias SG; van Diest PJ; van der Wall E; Siesling S; van Dalen T
    Ann Surg Oncol; 2019 Oct; 26(11):3495-3501. PubMed ID: 31209664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients.
    Blank PR; Filipits M; Dubsky P; Gutzwiller F; Lux MP; Brase JC; Weber KE; Rudas M; Greil R; Loibl S; Szucs TD; Kronenwett R; Schwenkglenks M; Gnant M
    Pharmacoeconomics; 2015 Feb; 33(2):179-90. PubMed ID: 25404424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the 21-gene recurrence score assay compared with standard clinicopathologic guidelines in adjuvant therapy selection for node-negative, estrogen receptor-positive breast cancer.
    Partin JF; Mamounas EP
    Ann Surg Oncol; 2011 Nov; 18(12):3399-406. PubMed ID: 21537874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial.
    van Nes JG; Seynaeve C; Maartense E; Roumen RM; de Jong RS; Beex LV; Meershoek-Klein Kranenbarg WM; Putter H; Nortier JW; van de Velde CJ;
    Ann Oncol; 2010 May; 21(5):974-82. PubMed ID: 19875752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy for breast cancer: practice patterns of community physicians.
    Harlan LC; Abrams J; Warren JL; Clegg L; Stevens J; Ballard-Barbash R
    J Clin Oncol; 2002 Apr; 20(7):1809-17. PubMed ID: 11919238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adjuvant treatment of breast cancer: meta-analysis and therapeutic recommendations].
    Jerusalem G; Bours V; Fillet G
    Rev Med Liege; 2000 May; 55(5):356-9. PubMed ID: 10941297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant! Online as a decision-making tool in early breast cancer--a UK national survey.
    Agarwal V; O'Neill P
    Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):159-60. PubMed ID: 21112194
    [No Abstract]   [Full Text] [Related]  

  • 11. Oncologists' weighing of the benefits and side effects of adjuvant systemic therapy: Has it changed over time?
    Engelhardt EG; de Haes HC; van de Velde CJ; Smets EM; Pieterse AH; Stiggelbout AM
    Acta Oncol; 2015 Jun; 54(6):956-9. PubMed ID: 25591819
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical Practice Guidelines for Breast Cancer: Current Limitations.
    Lüftner D
    Breast J; 2015; 21(4):450-3. PubMed ID: 25960106
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).
    Bueno-de-Mesquita JM; van Harten WH; Retel VP; van 't Veer LJ; van Dam FS; Karsenberg K; Douma KF; van Tinteren H; Peterse JL; Wesseling J; Wu TS; Atsma D; Rutgers EJ; Brink G; Floore AN; Glas AM; Roumen RM; Bellot FE; van Krimpen C; Rodenhuis S; van de Vijver MJ; Linn SC
    Lancet Oncol; 2007 Dec; 8(12):1079-1087. PubMed ID: 18042430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crossing the quality chasm in breast cancer care.
    Silliman RA
    J Clin Oncol; 2004 Sep; 22(18):3654-6. PubMed ID: 15289489
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical validity/utility, change in practice patterns, and economic implications of risk stratifiers to predict outcomes for early-stage breast cancer: a systematic review.
    Hornberger J; Alvarado MD; Rebecca C; Gutierrez HR; Yu TM; Gradishar WJ
    J Natl Cancer Inst; 2012 Jul; 104(14):1068-79. PubMed ID: 22767204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world patterns of endocrine therapy for metastatic hormone-receptor-positive (HR+)/human epidermal growth factor receptor-2-negative (HER2-) breast cancer patients in the United States: 2002-2012.
    Swallow E; Zhang J; Thomason D; Tan RD; Kageleiry A; Signorovitch J
    Curr Med Res Opin; 2014 Aug; 30(8):1537-45. PubMed ID: 24669852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adjuvant treatment of breast cancer in 2004. A review of the 8th consensus conference of St. Gallen and new study results].
    Kahlert S; von Koch F; Ditsch N; Untch M
    Gynakol Geburtshilfliche Rundsch; 2004 Apr; 44(2):102-12. PubMed ID: 15073439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: clinical validity/utility, change in practice patterns, and economic implications of risk stratifiers to predict outcomes for early-stage breast cancer: a systematic review.
    Lamy PJ; Martin PM; Romieu G; Jacot W
    J Natl Cancer Inst; 2013 Jan; 105(2):149. PubMed ID: 23243205
    [No Abstract]   [Full Text] [Related]  

  • 19. Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons' Referrals.
    Mamounas E; Poulos C; Goertz HP; González JM; Pugh A; Antao V
    Ann Surg Oncol; 2016 Oct; 23(11):3510-3517. PubMed ID: 27283292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International consensus meeting on the treatment of primary breast cancer 2001, St. Gallen, Switzerland.
    Thuerlimann B
    Breast Cancer; 2001; 8(4):294-7. PubMed ID: 11791120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.